Matthias P Nagele
Overview
Explore the profile of Matthias P Nagele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyaydin E, Gotschy A, Parianos D, Nagele M, Tudorache I, Flammer A, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39945978
Tricuspid regurgitation (TR) is a common valvular dysfunction following heart transplantation (HT), with reported prevalence rates ranging from 19 to 84%, primarily depending on the duration of follow-up. Its etiology...
2.
Laptseva N, Bitos K, Rossi V, Nebunu D, Haider T, Nagele M, et al.
Microvasc Res
. 2024 Dec;
158:104780.
PMID: 39708913
Background And Aims: Systemic sclerosis (SSc) is a systemic autoimmune disease, characterized by widespread microvasculopathy and fibrosis. Vascular and endothelial cell changes appear to precede other features of SSc. Retinal...
3.
Nagele M, Haider T, Kreysing L, Barthelmes J, Nebunu D, Rossi V, et al.
JACC Adv
. 2024 Nov;
3(12):101392.
PMID: 39606217
Background: The mechanism of how sacubitril/valsartan improves outcomes in heart failure with reduced ejection fraction (HFrEF) is still incompletely understood. Objectives: The aim of this trial was to delineate the...
4.
Alyaydin E, Parianos D, Hermes-Laufer J, Nagele M, Castro L, Papathanasiou M, et al.
Heart Fail Rev
. 2024 Nov;
30(2):327-335.
PMID: 39514145
In recent years, sodium-glucose co-transporter 2 inhibitors (SGLT2i) emerged as promising therapeutic agents in managing heart failure (HF). They demonstrated a significant impact on reducing HF hospitalizations and related mortality...
5.
Perez-Shibayama C, Gil-Cruz C, Cadosch N, Lutge M, Cheng H, De Martin A, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(3):301-316.
PMID: 39196111
Myocarditis is an inflammatory heart disease that leads to loss of cardiomyocytes and frequently precipitates fibrotic remodeling of the myocardium, culminating in heart failure. However, the molecular mechanisms underlying immune...
6.
Rossi V, Nebunu D, Nagele M, Barthelmes J, Haider T, Laptseva N, et al.
Clin Res Cardiol
. 2024 Aug;
PMID: 39167193
Background: A significant proportion of patients with heart failure (HF) progress to an advanced stage, which is associated with a substantial increase in morbidity and mortality. These patients may be...
7.
Nagele H, Rosenkranz M, Nagele M
Case Rep Neurol
. 2024 Aug;
16(1):204-207.
PMID: 39145134
Introduction: Causes of epileptic seizures are often multifactorial but for an effective therapy, they should be uncovered in detail. Case Presentation: We present a 67-year-old male patient with a central...
8.
Rossi V, Laptseva N, Nebunu D, Haider T, Nagele M, Ruschitzka F, et al.
Int J Cardiol
. 2023 Nov;
398:131592.
PMID: 37979794
Background: Cardiovascular (CV) risk factors and CV diseases, in particular heart failure, are strongly associated with impaired microvascular retinal endothelial function. Whether atrial fibrillation (AF) contributes to vascular dysfunction is...
9.
Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross-sectional study
Nagele M, Barthelmes J, Kreysing L, Haider T, Nebunu D, Ruschitzka F, et al.
Health Sci Rep
. 2022 Nov;
5(6):e880.
PMID: 36320653
Background And Aims: Sustained neurohormonal activation plays a central role in the progression of heart failure (HF). Other endocrine axes may also be affected. It was the aim of this...
10.
Nagele M, Flammer A
Curr Heart Fail Rep
. 2022 Oct;
19(6):375-385.
PMID: 36197627
Purpose Of Review: Heart failure (HF) after right ventricular myocardial infarction (RVMI) is common and complicates its clinical course. This review aims to provide a current overview on the characteristic...